PLACE OF THIS DOCUMENT IN THE VIEN GUT DOSSIER

A.1 is a foundation paper. It does not describe one specific clinical workflow and it is not limited to one disease axis. Its job is to establish the academic reference frame used by the whole Vien Gut dossier: WHAT – HOW – DATA-to-operate.

If A.0 is the architectural statement for the full dossier, A.1 answers the next question: what academic lens does this dossier use to look at the gap in modern medicine when caring for outpatients with complex chronic multimorbidity?

A.1 belongs to Layer 1 – Core architecture. It sits between the architectural statement in A.0 and the foundation concepts in A.2.

To read A.1 in its proper place, this document should be situated within the four-layer architecture of the dossier:

Layer 1 — Core architecture (Part A and Part B) A.1 belongs to Layer 1. It does not describe any single disease, but establishes the shared reference framework for all of Part A, Part B, Part C, and Part D.

Layer 2 — Application of the architecture to specific disease axes (Part C) The C documents can only be read correctly when the reader has first grasped A.1, because every C document operates on the same WHAT – HOW – DATA-to-operate framework.

Layer 3 — Appendices (protocols and procedures) The appendices are the detailed implementation layer of HOW. They cannot be understood separately from A.1, because without the reasoning framework in A.1, the reader may mistake protocols for a collection of disconnected clinical tricks.

Layer 4 — Academic dialogue, evidence benchmarking, and the roadmap to multicenter validation (Part D) Part D can only be formed academically if A.1 has already established the central question: what is modern medicine missing between evidence and practice, and what layer is the Vien Gut Model proposing in order to fill that gap.

ABSTRACT

A.1 explains the EBM reference frame used by the Vien Gut academic dossier. Its main point is simple: modern evidence-based medicine has developed the WHAT layer very strongly – treatment targets, evidence, guidelines, and disease-specific recommendations – but it does not automatically provide a full HOW layer for applying several guidelines to one patient over time, nor a full DATA-to-operate layer for making safe outpatient decisions in complex multimorbidity.

A.1 does not reject EBM. It treats EBM as the foundation of modern medicine. But it argues that when medicine moves from selected research populations to real people with several severe diseases at the same time, the usual disease-specific EBM chain reaches a structural break at the stage of clinical application.

That is why A.1 proposes a three-layer frame: WHAT, HOW, and DATA-to-operate. This frame is the direct conceptual base for Part B, Part C, and Part D. It also explains why high-value goals such as crystal-free status, dialysis deferral, prevention of heart-failure decompensation, and hepatic recompensation remain difficult in real practice if care lacks a structured operating model.